FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808485265> ?p ?o ?g. }

• W2808485265 endingPage "1411" @default.
• W2808485265 startingPage "1406" @default.
• W2808485265 abstract "Factor Xa (FXa) plays a critical role in the coagulation cascade by generation of thrombin. During focal ischemia thrombin levels increase in the brain tissue and cause neural damage. This study examined the hypothesis that administration of the FXa inhibitor, apixaban, following focal ischemic stroke may have therapeutic potential by decreasing brain thrombin activity and infarct volume. Male mice were divided into a treated groups that received different doses of apixaban (2, 20, 100 mg/kg administered I.P.) or saline (controls) immediately after blocking the middle cerebral artery (MCA). Thrombin activity was measured by a fluorescence assay on fresh coronal slices taken from the mice brains 24 hr following the MCA occlusion. Infarct volume was assessed using triphenyltetrazolium chloride staining. A high dose of apixaban (100 mg/kg) significantly decreased thrombin activity levels in the ipsilateral hemisphere compared to the control group (Slice#5, p = .016; Slice#6, p = .016; Slice#7, p = .016; Slice#8, p = .036; by the nonparametric Mann-Whitney test). In addition, treatment with apixaban doses of both 100 mg/kg (32 ± 8% vs. 76 ± 7% in the treatment vs. control groups respectively; p = .005 by the nonparametric Mann-Whitney test) and 20 mg/kg (43 ± 7% vs. 76 ± 7% in the treatment vs. control groups respectively; p = .019 by the nonparametric Mann-Whitney test) decreased infarct volumes in areas surrounding the ischemic core (Slices #3 and #8). No brain hemorrhages were observed either in the treated or control groups. In summary, I.P. administration of high dose of apixaban immediately after MCA occlusion decreases brain thrombin activity and reduces infarct size." @default.
• W2808485265 created "2018-06-21" @default.
• W2808485265 creator A5015646938 @default.
• W2808485265 creator A5024658913 @default.
• W2808485265 creator A5036384877 @default.
• W2808485265 creator A5041176328 @default.
• W2808485265 creator A5066754419 @default.
• W2808485265 creator A5072166912 @default.
• W2808485265 date "2018-05-14" @default.
• W2808485265 modified "2023-10-13" @default.
• W2808485265 title "Apixaban decreases brain thrombin activity in a male mouse model of acute ischemic stroke" @default.
• W2808485265 cites W1546405566 @default.
• W2808485265 cites W1594129908 @default.
• W2808485265 cites W1811402656 @default.
• W2808485265 cites W1816743455 @default.
• W2808485265 cites W1920409153 @default.
• W2808485265 cites W1964296989 @default.
• W2808485265 cites W1979228901 @default.
• W2808485265 cites W1979790930 @default.
• W2808485265 cites W1986962105 @default.
• W2808485265 cites W2017554966 @default.
• W2808485265 cites W2022593257 @default.
• W2808485265 cites W2027707602 @default.
• W2808485265 cites W2028341202 @default.
• W2808485265 cites W2037637421 @default.
• W2808485265 cites W2056303336 @default.
• W2808485265 cites W2058798231 @default.
• W2808485265 cites W2072664770 @default.
• W2808485265 cites W2085501100 @default.
• W2808485265 cites W2086164892 @default.
• W2808485265 cites W2098593694 @default.
• W2808485265 cites W2105536474 @default.
• W2808485265 cites W2112505121 @default.
• W2808485265 cites W2130373760 @default.
• W2808485265 cites W2142920553 @default.
• W2808485265 cites W2146721393 @default.
• W2808485265 cites W2155198114 @default.
• W2808485265 cites W2160311718 @default.
• W2808485265 cites W2162373453 @default.
• W2808485265 cites W2165113480 @default.
• W2808485265 cites W2165201687 @default.
• W2808485265 cites W2302463977 @default.
• W2808485265 doi "https://doi.org/10.1002/jnr.24253" @default.
• W2808485265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29761540" @default.
• W2808485265 hasPublicationYear "2018" @default.
• W2808485265 type Work @default.
• W2808485265 sameAs 2808485265 @default.
• W2808485265 citedByCount "13" @default.
• W2808485265 countsByYear W28084852652019 @default.
• W2808485265 countsByYear W28084852652020 @default.
• W2808485265 countsByYear W28084852652021 @default.
• W2808485265 countsByYear W28084852652022 @default.
• W2808485265 countsByYear W28084852652023 @default.
• W2808485265 crossrefType "journal-article" @default.
• W2808485265 hasAuthorship W2808485265A5015646938 @default.
• W2808485265 hasAuthorship W2808485265A5024658913 @default.
• W2808485265 hasAuthorship W2808485265A5036384877 @default.
• W2808485265 hasAuthorship W2808485265A5041176328 @default.
• W2808485265 hasAuthorship W2808485265A5066754419 @default.
• W2808485265 hasAuthorship W2808485265A5072166912 @default.
• W2808485265 hasConcept C126322002 @default.
• W2808485265 hasConcept C127413603 @default.
• W2808485265 hasConcept C2776301958 @default.
• W2808485265 hasConcept C2777292125 @default.
• W2808485265 hasConcept C2777397205 @default.
• W2808485265 hasConcept C2778661090 @default.
• W2808485265 hasConcept C2779161974 @default.
• W2808485265 hasConcept C2780638905 @default.
• W2808485265 hasConcept C2780645631 @default.
• W2808485265 hasConcept C42219234 @default.
• W2808485265 hasConcept C71924100 @default.
• W2808485265 hasConcept C78519656 @default.
• W2808485265 hasConcept C89560881 @default.
• W2808485265 hasConcept C98274493 @default.
• W2808485265 hasConceptScore W2808485265C126322002 @default.
• W2808485265 hasConceptScore W2808485265C127413603 @default.
• W2808485265 hasConceptScore W2808485265C2776301958 @default.
• W2808485265 hasConceptScore W2808485265C2777292125 @default.
• W2808485265 hasConceptScore W2808485265C2777397205 @default.
• W2808485265 hasConceptScore W2808485265C2778661090 @default.
• W2808485265 hasConceptScore W2808485265C2779161974 @default.
• W2808485265 hasConceptScore W2808485265C2780638905 @default.
• W2808485265 hasConceptScore W2808485265C2780645631 @default.
• W2808485265 hasConceptScore W2808485265C42219234 @default.
• W2808485265 hasConceptScore W2808485265C71924100 @default.
• W2808485265 hasConceptScore W2808485265C78519656 @default.
• W2808485265 hasConceptScore W2808485265C89560881 @default.
• W2808485265 hasConceptScore W2808485265C98274493 @default.
• W2808485265 hasFunder F4320332718 @default.
• W2808485265 hasIssue "8" @default.
• W2808485265 hasLocation W28084852651 @default.
• W2808485265 hasLocation W28084852652 @default.
• W2808485265 hasOpenAccess W2808485265 @default.
• W2808485265 hasPrimaryLocation W28084852651 @default.
• W2808485265 hasRelatedWork W1988788774 @default.
• W2808485265 hasRelatedWork W2283203477 @default.
• W2808485265 hasRelatedWork W2322364505 @default.
• W2808485265 hasRelatedWork W2523078145 @default.

• next